Higher SII levels are associated with higher TNM stages, higher tumor grades, sarcopenia, KRAS mutations, lymphovascular invasion, older age, and right-sided CRC [38,44,54,55,56,57,58,59]. This evidence concerns the gene KRAS and neoplasm.